VRCA - Massive Insider Trade At Verrica Pharmaceuticals | Benzinga
Joe Bonaccorso, Chief Commercial Officer at Verrica Pharmaceuticals (NASDAQ:VRCA), reported a large insider sell on November 16, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Bonaccorso sold 32,846 shares of Verrica Pharmaceuticals. The total transaction amounted to $96,689.
Verrica Pharmaceuticals shares are trading down 0.0% at $3.47 at the time of this writing on Friday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, however ...